Insider Selling: Lannett Company, Inc. (LCI) Major Shareholder Sells 10,000 Shares of Stock

Lannett Company, Inc. (NYSE:LCI) major shareholder David Farber sold 10,000 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $25.01, for a total value of $250,100.00. Following the completion of the sale, the insider now directly owns 4,171,269 shares in the company, valued at $104,323,437.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

David Farber also recently made the following trade(s):

  • On Wednesday, December 13th, David Farber sold 184 shares of Lannett stock. The stock was sold at an average price of $30.00, for a total value of $5,520.00.
  • On Tuesday, December 5th, David Farber sold 9,816 shares of Lannett stock. The shares were sold at an average price of $30.05, for a total value of $294,970.80.
  • On Friday, December 1st, David Farber sold 10,000 shares of Lannett stock. The shares were sold at an average price of $26.88, for a total value of $268,800.00.
  • On Wednesday, November 8th, David Farber sold 10,000 shares of Lannett stock. The shares were sold at an average price of $25.03, for a total value of $250,300.00.

Shares of Lannett Company, Inc. (NYSE LCI) opened at $24.85 on Friday. The company has a debt-to-equity ratio of 1.44, a current ratio of 2.52 and a quick ratio of 1.90. The company has a market capitalization of $936.84, a PE ratio of 22.19, a price-to-earnings-growth ratio of 1.58 and a beta of 2.85. Lannett Company, Inc. has a 1 year low of $14.90 and a 1 year high of $30.35.

Lannett (NYSE:LCI) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.08. The business had revenue of $155.00 million during the quarter, compared to analysts’ expectations of $153.62 million. Lannett had a return on equity of 9.35% and a net margin of 8.56%. The business’s quarterly revenue was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.77 earnings per share. sell-side analysts expect that Lannett Company, Inc. will post 3.04 EPS for the current year.

A number of research analysts have recently issued reports on the company. Zacks Investment Research downgraded Lannett from a “buy” rating to a “hold” rating in a report on Wednesday, December 13th. Oppenheimer reaffirmed a “hold” rating on shares of Lannett in a report on Monday, December 11th. ValuEngine raised Lannett from a “hold” rating to a “buy” rating in a report on Saturday, November 25th. Finally, BMO Capital Markets increased their target price on Lannett from $20.00 to $22.00 and gave the company a “market perform” rating in a report on Monday, November 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $23.60.

A number of institutional investors and hedge funds have recently modified their holdings of the business. SRS Capital Advisors Inc. increased its position in Lannett by 15,202.7% in the third quarter. SRS Capital Advisors Inc. now owns 16,833 shares of the company’s stock worth $310,000 after buying an additional 16,723 shares in the last quarter. Neuberger Berman Group LLC purchased a new stake in Lannett in the third quarter worth about $188,000. California Public Employees Retirement System increased its position in Lannett by 3.9% in the third quarter. California Public Employees Retirement System now owns 81,146 shares of the company’s stock worth $1,497,000 after buying an additional 3,046 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in Lannett in the third quarter worth about $700,000. Finally, Cornerstone Capital Management Holdings LLC. purchased a new stake in Lannett in the third quarter worth about $414,000. Institutional investors and hedge funds own 97.17% of the company’s stock.

WARNING: “Insider Selling: Lannett Company, Inc. (LCI) Major Shareholder Sells 10,000 Shares of Stock” was published by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.themarketsdaily.com/2018/01/12/insider-selling-lannett-company-inc-lci-major-shareholder-sells-10000-shares-of-stock.html.

About Lannett

Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.

Insider Buying and Selling by Quarter for Lannett (NYSE:LCI)

Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply